Cargando…
Limits to clinical trials in surgical areas
Randomized clinical trials are considered to be the gold standard of evidence‐based medicine nowadays. However, it is important that we point out some limitations of randomized clinical trials relating to surgical interventions. There are limitations that affect the external and internal validity of...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3044561/ https://www.ncbi.nlm.nih.gov/pubmed/21437453 http://dx.doi.org/10.1590/S1807-59322011000100027 |
_version_ | 1782198736875683840 |
---|---|
author | Demange, Marco Kawamura Fregni, Felipe |
author_facet | Demange, Marco Kawamura Fregni, Felipe |
author_sort | Demange, Marco Kawamura |
collection | PubMed |
description | Randomized clinical trials are considered to be the gold standard of evidence‐based medicine nowadays. However, it is important that we point out some limitations of randomized clinical trials relating to surgical interventions. There are limitations that affect the external and internal validity of many surgical study designs. Some limitations can be bypassed, but can make it more difficult for the study to be carried out. Other limitations cannot be bypassed. When it is intended to extrapolate the result of a randomized clinical trial, the premise is that the performed or to be performed intervention will be similar wherever applied and/or for every doctor using it. However, no matter how standardized the technique may be, the results are not similar for all surgeons, which implies a significant limitation to surgical randomized clinical trials concerning external validity. When considering the various limitations presented for performing surgical trials capable of generating scientific evidence within the patterns currently proposed in the evidence level classifications of medical publications, it is necessary to rethink whether those scientific evidence levels are similarly applicable to surgical works and to nonsurgical trials. We currently live in a time of supposed “inferiority” of surgical scientific works under the optics of the current quality criteria for a “suitable” clinical trial. |
format | Text |
id | pubmed-3044561 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo |
record_format | MEDLINE/PubMed |
spelling | pubmed-30445612011-02-24 Limits to clinical trials in surgical areas Demange, Marco Kawamura Fregni, Felipe Clinics (Sao Paulo) Review Randomized clinical trials are considered to be the gold standard of evidence‐based medicine nowadays. However, it is important that we point out some limitations of randomized clinical trials relating to surgical interventions. There are limitations that affect the external and internal validity of many surgical study designs. Some limitations can be bypassed, but can make it more difficult for the study to be carried out. Other limitations cannot be bypassed. When it is intended to extrapolate the result of a randomized clinical trial, the premise is that the performed or to be performed intervention will be similar wherever applied and/or for every doctor using it. However, no matter how standardized the technique may be, the results are not similar for all surgeons, which implies a significant limitation to surgical randomized clinical trials concerning external validity. When considering the various limitations presented for performing surgical trials capable of generating scientific evidence within the patterns currently proposed in the evidence level classifications of medical publications, it is necessary to rethink whether those scientific evidence levels are similarly applicable to surgical works and to nonsurgical trials. We currently live in a time of supposed “inferiority” of surgical scientific works under the optics of the current quality criteria for a “suitable” clinical trial. Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2011-01 /pmc/articles/PMC3044561/ /pubmed/21437453 http://dx.doi.org/10.1590/S1807-59322011000100027 Text en Copyright © 2011 Hospital das Clínicas da FMUSP http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Demange, Marco Kawamura Fregni, Felipe Limits to clinical trials in surgical areas |
title | Limits to clinical trials in surgical areas |
title_full | Limits to clinical trials in surgical areas |
title_fullStr | Limits to clinical trials in surgical areas |
title_full_unstemmed | Limits to clinical trials in surgical areas |
title_short | Limits to clinical trials in surgical areas |
title_sort | limits to clinical trials in surgical areas |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3044561/ https://www.ncbi.nlm.nih.gov/pubmed/21437453 http://dx.doi.org/10.1590/S1807-59322011000100027 |
work_keys_str_mv | AT demangemarcokawamura limitstoclinicaltrialsinsurgicalareas AT fregnifelipe limitstoclinicaltrialsinsurgicalareas |